key: cord-1050806-njzgateb authors: Banerjee, S.; Saha, A. title: Finding Tentative Causes for the reduced impact of Covid-19 on the Health Systems of poorer and developing nations: An ecological study of the effect of demographic, climatological and health-related factors on the global spread of Covid-19 date: 2020-05-26 journal: nan DOI: 10.1101/2020.05.25.20113092 sha: ce102d704dc888c8ae68ec9d1be692c4753d9e2d doc_id: 1050806 cord_uid: njzgateb Objective - The objective of this study is to evaluate the association with different factors empirically found to affect the spread and the severity of Covid-19. Evidently there is less likelihood of having one single and absolute solution to this pandemic. It is pragmatic to look for a multi-pronged and collaborative assembly of probable solutions, which is the higher objective of this study. Design - Ecological study. Setting - Global setting including 45 countries from all six inhabited continents Population Two (2) or three (3) countries from each geographical region of the continents selected on the basis of population Main outcome - measures correlation factors derived from comparisons between different sets of variables Results - Empirical trends suggested in the existing literature were quantified in a global setting establishing clear trends. Correlation between the proportion of the population affected and median age, prime climate zones, malaria and tuberculosis incidence, BCG coverage and mitigation measures were established. Conclusions The study findings suggest that demographic and climatological factors, high endemicity of TB and Malaria, and universal BCG programmes may have a cushioning effect in the impact of Covid-19 on health systems of poorer and developing nations. In the light of these findings more emphasis is necessary on the protective effects of BCG and antiviral properties of antimalarial drugs. This study takes a comprehensive look into the global patterns of incidence of with respect to demographic, climatological and health related determinants and mitigation efforts of various countries. Trends in Italy and South Korea suggest a dramatically higher burden of mortality from 4 Covid-19 in countries with older populations. Covid-19 related morbidity and mortality rates are associated with the median ages of the respective countries. WHO surveillance 5 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 26, 2020 May 26, . . https://doi.org/10.1101 May 26, /2020 doi: medRxiv preprint data shows a progressively higher proportion of cases belonging to the 20-39 age-group, 6 but case fatality rates are seen to increase with age 3 . There is some concern that high population densities would catalyse the spread of the disease . However, a study of 8 cities with high spread of the disease noted the lack of 7 significant community spread in expected locations based only on high population proximity and extensive interaction through travel . 8 Studies conducted in Wuhan , in a group of Chinese cities , in Jakarta, Indonesia and 9 10 11 Iran found that higher temperature, relative humidity, wind speed, and solar radiation 12 reduced the transmission of Covid-19. Significant spread has been noted 8 in cities and regions lying between 30 and 50 degree latitude with average temperatures of 5-11 degree celsius and low specific and absolute humidity. Between January -March 2020 incidence had peaked in temperate regions of the northern hemisphere in and were lower in both warmer/wetter and colder/dryer regions . However, a United States-based 13 model of SARS-CoV-2 transmission found that it could proliferate in any time of the 14 year. Other studies have commented that virus transmission had no seasonality and 15 spanned all climatic zones. A standing committee of the National Academies of 16 Sciences, Engineering, and Medicine, the USA, stated that factors such as temperature and humidity would not lead to any significant reduction in the disease spread due to the lack of pre-existing immunity globally. A comparison of distribution maps of Beta-CoVs diseases (MERS, 17 and malaria incidence unveiled an inverse relationship. However the WHO refused to 18 give any reassurance as it reported that the African region which carries 90% of the global Malaria burden had reported 25000 cases of Covid-19 as of 30th April 2020. The available literature has mostly focused on the association of each of these determinants separately with morbidity and mortality from Covid-19, mostly in regional or national contexts and findings are self-contradictory. This study focuses more on the spread of the disease in terms of proportion of the population affected with Covid-19 rather than morbidity and mortality; it considers all these variables simultaneously to . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 26, 2020 . . https://doi.org/10.1101 give a more complete picture; with a global context using quantitative analysis to prove empirical trends. The objective of this study was to evaluate the association of different factors empirically found to affect the spread and the severity of Covid-19. An ecological study with a mixed methodological approach was undertaken.This approach was appropriate considering the global scale of the pandemic and the large number of variables that could affect its spread. Qualitative methods were used to analyse climate classification based spread of the disease and the impact of lockdown measures on the epidemiological curve. Quantitative methods were used to find the geographical correlation between selected demographic variables, health determinants and the disease incidence and mortality. Data sourced from accredited organisations available in the public domain for 45 countries distributed over each different geographical region of six continents were selected to be studied based on their population. The demographic data including population as on 1st July 2019, life expectancy, population density and median age were collected from the worldometers website which has sourced its data from the World wise statistical data about Covid-19, sourced mainly from government data of the respective countries, as updated till 30th April 2020 was collected; this included the country-wise date of first report, total number of reported cases, date of first death, total deaths, total tests, recovered, highest number of cases in a day, date and number of cases on peak day, and date and number of cases on the day with the second highest case count. The case fatality rate (total deaths with respect to total reported cases), specific mortality rate (per million population), average recovery rate, number of days until and from the spike and number of days from the second highest report in a day till the peak day were calculated for each country. Country-wise data on the incidence of Malaria per thousand population were collected from global health observatory, WHO . Data on 30 incidence of tuberculosis by country were obtained from the World Bank website . BCG 31 coverage, and duration of years of BCG administration for those countries with universal coverage was obtained from WHO data . The nature of combat measures adopted in 32 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 26, 2020. . https://doi.org/10.1101/2020.05.25.20113092 doi: medRxiv preprint some of the countries, for example whether selective or stringent lockdown measures were imposed, was found from widely circulated and referred media sources. The data collected is represented in a master table in Appendix 1. Abbreviations have been used for country names, as listed in the table, for the ease of diagrammatic representation. Geospatial comparison of Koppen-Geiger classification with Covid-19 case distribution from the WHO dashboard was followed by cross-tabulation of Koppen climate classifications most prevalent in the selected countries with the total number of cases and proportion of the population affected. The association between the quantitative demographic and health-related data with the number of Covid-19 cases in each country was examined using graphical representation followed by bivariate analysis and calculation of correlation coefficients. Similar geographical correlations were done of the data with the percentage of the populations affected and the case fatality rate. The percentage of Covid-19 cases in the population has a significant positive correlation with the median age of the respective countries (r= 0.595), as shown in Figure 1 . The case fatality rate is also positively associated with the median age (r=0.32). Population density is weakly associated (r=0.16) with the percentage of positive cases among those tested for Covid-19, and has no correlation (r=0) with the total number of cases or with the percentage of the total population affected with Covid-19 (r= -0.03). The total number of cases reported varies proportionately with the total number of tests done (r=0.89). However, the percentage of cases among those tested is not significantly associated (r= 0.16) with the total number of tests done. Cross-tabulation of most prevalent Koppen-Geiger climate conditions with the percentage of the population affected with Covid-19 as shown in Figure 2 , reveals that the highest percentage of cases are noted in Oceanic (Cfb), Humid subtropical (Cwa, Cfa), Humid continental (Dfb), Tropical Savannah (Aw), and Semi Arid hot (BSh) climate zones. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 26, 2020. . https://doi.org/10. 1101 The percentage of the population affected with Covid-19 is inversely related to the incidence of malaria in that population (r=-0.28), as shown in Figure 3 . The total number of reported cases of Covid-19 also decreases slightly with the higher incidence of malaria (r=-0.16). (To calculate these correlation values reported incidence of 0 was substituted as 0.001). The percentage of the population affected with Covid-19 decreases with higher incidence rates of tuberculosis (r =-0.4), as demonstrated in Figure 4 . Also the height of the peak (the highest number of cases reported in a day) is observed less with increasing incidence of tuberculosis (r=-0.25). A more gradual curve (longer interval from second highest peak day till peak day) is weakly associated with a lower peak number of cases reported on peak day (r= -0.12). The more the number of days until the spike the higher it was (r=0.39), that is the number of cases reported on peak day was greater. The case fatality rate increased when the duration to the spike was prolonged (r=0.26). . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 26, 2020. . https://doi.org/10. 1101 The correlation between the percentage of cases in the total population and the median age of the population indicates that the diagnosis of the disease is more likely in older adults, which may be due to increased symptom burden and different care-seeking behaviour. That there is no geographical correlation between population density and percentage of the population affected by Covid-19, shows that it is incorrect to assume that regions with high population densities would be incapable of abiding by social distancing norms and would thus inevitably report high incidence of the disease. Widespread therapeutic and prophylactic use of chloroquine and hydroxychloroquine in areas of malaria endemicity, associated with higher physician comfort in instructing offlabel use of these drugs for Covid-19 suspects and cases, may be causally associated with the reduced incidence of Covid-19, and subsequent lower case fatality rates in these countries. Prescription of antimalarial drugs on the basis of clinical suspicion for fevers of unknown origin where laboratory diagnosis is not immediately possible, is a common practice in malaria endemic regions, and affords good clinical outcomes. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 26, 2020. . https://doi.org/10. 1101 The strength of the negative association between BCG coverage and country-wise case fatality rates of Covid-19 (r=-0.33) is almost equal to the correlation between median age and case fatality rates (r=0.32). The increased risk of mortality in older age groups has widely been accepted by the WHO and the scientific community. Hence, statistically the protective effect of BCG vaccination is as strong as the impact of morbidity enforced by increased age. The increased mortality with age might also be explained in part by the waning of vaccine efficacy of the BCG vaccine after 40 years . 33 The finding of lower incidence of Covid-19 with BCG coverage and endemicity of malaria and TB might not be merely circumstantial evidence.When a virus infects cells of a body, the body immediately mounts a non-specific innate response consisting of neutrophils, The administration of BCG can also change the cytokine profile in subjects leading to the reduced incidence of Covid-19 in regions reporting higher BCG coverage. The missing link in this may be recent RCTs demonstrating the induction of immunity and protective 41 efficacy of the anti-tubercular vaccine BCG against controlled human malaria infection due to changes in the innate immune system that lead to earlier phenotypic monocyte activation and expression of NK cell activation markers that is inversely correlated with parasites on malaria challenge. A recently published multi centre prospective randomised trial in Hong Kong has found IFN beta-1b, a Type 1 IFN, to be effective in combination 42 with the antiretroviral lopinavir-ritonavir and the antiviral ribavirin reducing the mean . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 26, 2020 . . https://doi.org/10.1101 Page of 10 15 duration of disease (start of treatment till negative nasopharyngeal swab) lending further strength to the hypothesis that higher IFN type 1 levels would lead to lower manifestation of symptoms and reduced morbidity from the Covid-19 disease. The choice of mitigation measures by different populations seem to be more of a response to the epidemiological curve rather than a determining factor. This explains why no clear trend of delayed and diminished peaks are seen with stricter social distancing norms. Data about lockdown measures has been collected as a measure of the respective country's response to the onslaught of the epidemic. This data may be useful in later studies to compare the impact of the epidemic itself with the magnitude of the impact of our collective response. A study of acute antibody responses to SARS-CoV-2 in 285 patient found all patients 43 tested positive for IgG within 19 days after symptom onset. However total measurable antibody is not the same as functional protective antibody. No study has concretely evaluated whether the presence of antibodies to SARS-CoV-2 confers immunity to subsequent infections by the virus . On a community scale this means it cannot yet be 44 assumed that if infection and subsequent immunity levels in populations reach the critical proportions needed for the achievement of herd immunity it would halt the epidemic. It seems prudent to add that if it is indeed found that the detected IgG do confer immunity to reinfection over a period of time (1-4 years based on studies of closely related coronaviruses) at least 60% of the population would need to have protective immunity (considering an R 0 of 2.2, with estimates being higher if R 0 is underestimated , and 45 varying with effective reproduction number or R t from population to population) in order to halt further spread in that population . The number of people who need to be 46 vaccinated in order to attain herd immunity were also calculated based on an Ro of 2.2. The huge populations living in developing and underdeveloped countries will need to have access to the vaccine in sufficient numbers for any protective effect at the community level. This would need planning and forethought to ensure that once the vaccine is available it can be administered as soon and as widely as is necessary to truncate the effect of the epidemic. Having said that, it will be prudent to assume that to achieve the critical number through vaccination would require decades of immunisation effort. It can be summarised that even if there is this effective vaccine with no/less negative longterm or short-term health implication, there is no quick escape from this situation. Which strengthens the necessity of multiple reviews of our existing arsenal of mitigation of any health emergency rather that being consistently sceptical about those. It . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 26, 2020. . https://doi.org/10.1101/2020.05.25.20113092 doi: medRxiv preprint is evident that it is less likely to have one single and absolute solution to this pandemic, so it'll be wise to look for a multi-pronged and collaborative assembly of probable solutions, which is the ultimate goal of this study. We could not obtain excess mortality rates for the time period of the epidemic for many of the selected countries. Attributable risk from BCG vaccination could not be calculated because health data of the infected population could not be sourced in the public domain. We could not obtain complete data of therapeutics being used or of mitigation and alleged suppression tactics used in different countries. All the data was sourced from public domain websites which may have some inaccuracies of their own. In confirmation of trends suggested by empirical data this study found a strong geographical correlation between median age and total number of cases of Covid-19 and also a positive relationship between median age and the average death rate. Data from 45 countries spread over all inhabited continents were analysed to find that a larger proportion of cases were occurring in Oceanic (Cfb), Humid subtropical (Cwa, Cfa), Humid continental (Dfb), Tropical Savannah (Aw), and Semi Arid hot (BSh) climate zones. Confirming empirical data it was found that global trends indicated that higher malaria incidence correlated well with lower case burden of Covid-19. The prevalent use of chloroquine and hydroxychloroquine in malaria endemic zones could be a reason for the reduced case burden and burden of mortality from Covid-19 in these areas. The protective effect of the BCG vaccine was quantified in terms of its correlation with reduced incidence of Covid-19 and was found almost equal in magnitude to the deleterious effect of age. It has been hypothesised that in addition to trained immunity, higher levels of Type 1 interferon was responsible for this protective effect. More stringent social distancing measures were also found to have a positive effect on disease control. However it is important to note that the countries of Africa, Asia and South America with lower median ages and higher incidence of malaria and tuberculosis, along with higher BCG coverage already have lower life expectancies, and strained health systems, with much lower health system performance indices which may eventually cancel out any . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 26, 2020 . . https://doi.org/10.1101 Page of 12 15 protective effects of these combination of favourable factors in case of a typical massive outbreak. So while we cannot derive any reassurance of reduced impact in the poor and developing nations, as the threshold of number of total cases needed to surge might fall far too short of the need based projected and report based actual strength of their existing health systems. But this study holds that the discussed impact of outliers might as well be the reasons behind any reduction to the expected load of cases in those countries, rather that attributing those reductions unto 'unknown' factors. Given that possibility we can inclusively use this data and study to better understand the course the disease might follow in the future. The findings of the study also underline the need for more widespread clinical trials of hydroxychloroquine and the BCG vaccine in the prophylaxis and treatment of Covid-19. The rapid and long lasting immunological modifications caused by the BCG vaccine which confer some protection to viral respiratory tract infections may be put to use by administering BCG prophylactically to health care workers and high risk populations. The adverse effects of BCG vaccination are few and its long term effects are well documented. The side effect profile of chloroquine and hydroxychloroquine are also well known to the medical community and can be avoided by simple precautions before prescribing. On the other hand the cost of developing and producing a new vaccine in sufficient numbers needed for a herd immunity are significantly higher and the long term effects of any new vaccine would be unknown in spite of clinical trials. The human cost and suffering of continuing economic lockdown until the development of a vaccine are unsustainable in the developing and poorer nations and the long term effects of the poverty and undernutrition induced by these mitigation efforts may equal or likely surpass the burden of morbidity and mortality from the disease itself. The evidence found in this study suggests that it would be far more rational to thoroughly explore the scope of using the BCG vaccine, chloroquine and hydroxychloroquine to reduce the incidence and morbidity of the disease in the population and thus spare the already strained capacities of health systems in the developing and poorer countries to whatever extent is possible. Refer Supplement . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 26, 2020 . . https://doi.org/10.1101 Luo, Effects of temperature variation and humidity on the death of COVID-19 in Wuhan, China, Science of The Total Environment, Volume 724, 2020 ,138226, ISSN 0048-9697, https://doi.org/10.1016 / j.scitotenv.2020 the Transmission of COVID-19 (March 9, 2020) . Available at SSRN: https://ssrn.com/abstract=3551767 or http://dx.doi.org/10.2139/ssrn.3551767 Ramadhan Tosepu, Joko Gunawan, Devi Savitri Effendy, La Ode Ali Imran Ahmad, Hariati Lestari, Hartati 11 Bahar, Pitrah Asfian, Correlation between weather and Covid-19 pandemic in Jakarta, Indonesia, Science of The Total Environment, Volume 725, 2020 , 138436, ISSN 0048-9697, https://doi.org/10.1016 / j.scitotenv.2020 Investigation of effective climatology parameters on COVID-19 outbreak in Iran, Science of The Total Environment, Volume 729, 2020 , 138705, ISSN 0048-9697, https://doi.org/10.1016 / j.scitotenv.2020 Gentile Francesco Ficetola, Diego Rubolini, Climate affects global patterns of COVID-19 early outbreak 13 dynamics. medRxiv 2020.03.23.20040501; doi: https://doi.org/10.1101/2020.03.23.20040501 Stephen M. Kissler, Christine Tedijanto, Edward Goldstein, Yonatan H. Grad, Marc Lipsitch, Projecting the 14 transmission dynamics of SARS-CoV-2 through the postpandemic period, PUBLISHED ONLINE14 APR 2020 , SCIENCE 22 MAY 2020 : 860-868, DOI: 10.1126 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted May 26, 2020 . . https://doi.org/10.1101 Download/Standard/Population/ Kottek, M., J. Grieser, C. Beck, B. Rudolf, and F. Rubel, 2006 : World Map of the Köppen-Geiger climate 28 classification updated. Meteorol. Z., 15, 259-263. DOI: 10.1127 /0941-2948 /2006 Incidence Data by Country, Malaria, Global Health Observatory Data Repository, WHO, https:// 30 apps.who.int/gho/data/view.main.MALARIAINCIDENCEv?lang=en . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted May 26, 2020 . . https://doi.org/10.1101 Coronavirus: covid-19 has killed more people than SARS and MERS combined, despite 1 lower case fatality rate Global Spread of Coronavirus Disease 2019 and Malaria the Early Stage of A Pandemic Department of Communications Demographic science aids in understanding the spread and fatality rates of COVID-19 Are BCG Vaccination Important Determinants of COVID-19 Pandemic Spread Coronavirus disease 2019 (COVID-19) Situation Report-89 High population densities catalyse the spread of Covid-19 Humidity and Latitude Analysis to Predict Potential Spread and Seasonality for COVID-19 Bin 9 of climate in COVID-19 mitigation strategies Potential Effects of Seasonal and Temperature Changes on Spread of COVID-19 Examined in New Rapid 16 Response to Government from Standing Committee on Emerging Infectious Diseases Global Spread of Coronavirus Disease 2019 and Malaria: An Epidemiological Paradox in 17 the Early Stage of A Pandemic A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19 Chloroquine or hydroxychloroquine for prevention and 20 treatment of COVID-19 Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study Chapter 6 -The Heterologous Effects of Bacillus Calmette-23 Editor(s): Denise L. Faustman,The Value of BCG Could BCG be used to protect against COVID-19? mitigation measures influence the course of the COVID-19 epidemic? Countries in the world by population United Nations, Population Division BCG Immunisation Coverage estimates by Country, Global Health Observatory Data Repository Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study The powerful immune system against powerful COVID-19: A 34 hypothesis Type I interferons in tuberculosis: Foe 36 and occasionally friend Type I Interferons Regulate Immune Responses in Humans with Blood-Stage Plasmodium falciparum Infection Interferon-alpha receptor-1 (IFNAR1) variants are associated with 38 protection against cerebral malaria in The Gambia Type I Interferons in the Pathogenesis 39 of Tuberculosis: Molecular Drivers and Immunological Consequences IFN-α Boosting of Mycobacterium bovis Bacillus Calmette Güerin-Vaccine 40 Promoted Th1 Type Cellular Response and Protection against M. tuberculosis Infection Outcomes of controlled human malaria infection after BCG 41 vaccination Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial, The Lancet 2020/05/25 Antibody responses to SARS-CoV-2 in patients 43 with COVID-19 What policy makers need to know about COVID-19 45 protective immunity Herd immunity -estimating the level required to halt the